European Journal of Cancer
Volume 41, Issue 13 , Pages 1842-1853, September 2005

Inhibition of survival signalling by dietary polyphenols and indole-3-carbinol

Cancer Biomarkers and Prevention Group, Departments of Biochemistry and Cancer Studies, Biocentre, University of Leicester, University Road, Leicester LE1 7RH, UK

Received 1 March 2005; accepted 3 May 2005.

Abstract 

Epidemiological studies have long hinted at the possibility that what we eat greatly influences our state of health, in particular our relative risk of developing cancer. In recent years there has been an exponential increase in the number of studies investigating how individual components of the diet interact at the molecular level to determine the fate of a cell. It is now apparent that many such molecules can preferentially inhibit the growth of tumour cells, by inducing cell cycle arrest or apoptosis. The number of signalling pathways and molecular targets involved is continually expanding. Consequently, the picture is becoming ever more complicated, not least because results often appear to be cell-type specific, dose–response relationships are critical, and any one agent appears to have multiple mechanisms of action. In addition most studies have been conducted in cell culture, often with physiologically unachievable concentrations of single agents, making extrapolation to the clinical situation difficult. In this review the mechanisms of action of a few well-studied dietary polyphenols (curcumin, epigallocatechin gallate and resveratrol) and indole-3 carbinol are considered in the light of these issues.

Keywords: Chemoprevention, Survival signalling, Curcumin, Epigallocatechin gallate, Indole-3-carbinol, Resveratrol, MAPK, PI3K, NF-κB, STAT

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0959-8049(05)00473-9

doi:10.1016/j.ejca.2005.05.008

European Journal of Cancer
Volume 41, Issue 13 , Pages 1842-1853, September 2005